Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 2/2020

01-12-2020 | Migraine | BRIEF COMMUNICATION

Efficacy and safety of erenumab in the real-life setting of S. Antonio Abate Hospital’s Headache Center (Gallarate)

Authors: Elisabetta Dalla Valle, Manlio Di Falco, Andrea Mancioli, Simona Corbetta, Isidoro La Spina

Published in: Neurological Sciences | Special Issue 2/2020

Login to get access

Excerpt

We aimed to assess the efficacy and safety of erenumab, a fully monoclonal antibody inhibiting the calcitonin gene-related peptide receptor (CGRPr), for the prevention of migraine in a real-life setting with long-term follow-up (40 weeks). …
Literature
1.
Stewart WF et al (1999) An international Study to Assess Reliability of Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994CrossRef
2.
Reuter U et al (2018) Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double blind, placebo controlled, phase 3b study. Lancet 10161:2280–2287CrossRef
Metadata
Title
Efficacy and safety of erenumab in the real-life setting of S. Antonio Abate Hospital’s Headache Center (Gallarate)
Authors
Elisabetta Dalla Valle
Manlio Di Falco
Andrea Mancioli
Simona Corbetta
Isidoro La Spina
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue Special Issue 2/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04752-4

Other articles of this Special Issue 2/2020

Neurological Sciences 2/2020 Go to the issue

BRIEF COMMUNICATION

Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series

BRIEF COMMUNICATION

Headache in a group of SARS-COVID-19 patients: an observational prospectical study

BRIEF COMMUNICATION

Effectiveness of mindfulness by smartphone, for patients with chronic migraine and medication overuse during the Covid-19 emergency

BRIEF COMMUNICATION

Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study

HEADACHES AND CEREBROVASCULAR DISEASE

Headache in cerebral venous thrombosis

BRIEF COMMUNICATION

Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis